Inc. During Dr. Nau’s tenure as CEO of Oyster Point Pharma, he successfully guided the company through its initial public offering in 2019, secured over $300 million in funding, and ultimately ...

Now, the hope is that within the next 12 to 18 months, the insights will point doctors and eventually pharma to viable treatments for long COVID, which has seen limited scientific progress in ...

Explore all key property features for 3 Oyster Point Drive, Stansbury. Click here to find out more. What is the size of the property at 3 Oyster Point Drive, Stansbury? The external land size for ...

Morningstar brands and products Company Portfolio ...

Venture investors hope Oyster Point Pharma will be the next biotech startup to make an impact on the giant market for dry-eye treatments. Powered by new technologies, many services that are ...

Through developing Havas Lynx’s proprietary data product, Point.1, we’ve found that only 19% of healthcare professionals (HCPs) trust pharma branded content. With HCPs receiving 1,000+ competitive ...

Innate Pharma (IPHA) announced review of its January 2016 research collaboration and license agreement with Sanofi (SNY): As previously disclosed, Sanofi will opt to pursue the development of SAR ...

RBC Capital analyst Luca Issi maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) on April 3 and set a price target of $330.00. The company’s shares closed yesterday at $235.74.

A new poll suggests roughly a fourth of GOP voters support giving the president authority over the rule of law and civic institutions. By Steve Benen While Donald Trump’s allies keep trying to ...

After a slam dunk first season, the team behind Running Point — the Warner Bros. Television show loosely based on Los Angeles Lakers owner and president Jeanie Buss’ life and stewardship ...

The pharmaceutical industry has a crucial role in modern healthcare, but it also has a significant environmental footprint. From large-scale solvent use and carbon emissions to water pollution and ...